3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Lymphoma, Follicular
3
Brain Neoplasms
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Immunoblastic Lymphadenopathy
2
Hodgkin Disease
2
Gliosarcoma
2
Glioblastoma
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Sarcoma, Kaposi
1
Sarcoma
1
Renal Insufficiency
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Interventions
Radiotherapy
6
Radiation
3
Panobinostat
3
Cyclophosphamide
3
ribociclib
2
Temozolomide
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Everolimus
2
Etoposide
2
Dasatinib
2
vandetanib
1
temsirolimus
1
spartalizumab
1
sargramostim
1
reolysin
1
pembrolizumab
1
ovex
1
marizomib
1
irinotecan sucrosofate
1
gallium maltolate
1
etoposide phosphate
1
crenolanib
1
balstilimab
1
adavosertib
1
abemaciclib
1
X-Rays
1
Vorinostat
1
Vaccines
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Diffuse Intrinsic Pontine Glioma
×
Cilengitide
×
Clear all
NCT01165333
2026-03-16
CILENT
Centre Oscar Lambret
Phase 1
Completed
32 enrolled